Heart implant is a breakthrough (twice)

I reported previously (see here) on the interatrial shunt developed by Israel’s V-Wave. The US FDA has just granted two Breakthrough Device Designations to the device – the first is for Heart Failure (HF), and the second, for Pulmonary Arterial Hypertension (PAH).


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *